Jan 22 (Reuters) - Corcept Therapeutics said on Thursday a late-stage trial showed its experimental drug in combination with ...

Corcept recently suffered a blow after relacorilant was rejected by the FDA for use in Cushing’s syndrome.

As soon as the urologist said, oh it’s cancer…that is an eye-opener,” says Mark Stiegler, reflecting on his diagnosis six ...

Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, researchers are using the same tactics to advance prostate cancer treatment.

Researchers at Mount Sinai launch a new AI platform to match more cancer patients with clinical trials, aiming to expand ...

Head and neck cancer trials are frequently derailed before they can deliver answers. A new analysis suggests that the most ...

Our daughter was recently diagnosed with cancer. She's interested in participating in a clinical trial but doesn't really ...

A Phase III clinical trial including patients at the University of Oklahoma found that proton therapy improved survival and resulted in fewer side effects among people with head and neck cancer. The ...

The only man in his immediate family to be without a cancer diagnosis, one Lynch syndrome patient made the trip to ...

Experts discuss the current status of neoadjuvant ADC therapies, eligibility criteria, and future treatment pathways for high-risk patients.

Medical professionals in New York have partnered with a few others nationwide using new methods to study cancer treatments. The Cancer Research Institute said its “Discovery Engine” will help generate ...

Johns Hopkins University cancer researcher Mikala Egeblad has received the 2025 Ernst W. Bertner Memorial Award in ...